123 filings
8-K
NMTC
NeuroOne Medical Technologies Corporation
13 Sep 24
Departure of Directors or Certain Officers
4:30pm
8-K
NMTC
NeuroOne Medical Technologies Corporation
14 Aug 24
NeuroOne® Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
4:15pm
8-K
NMTC
NeuroOne Medical Technologies Corporation
7 Aug 24
Entry into a Material Definitive Agreement
4:30pm
8-K
NMTC
NeuroOne Medical Technologies Corporation
12 Jul 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:49pm
8-K
NMTC
NeuroOne Medical Technologies Corporation
21 Jun 24
Material Modifications to Rights of Security Holders
4:15pm
8-K
vy4 4sus8tt0bo
14 May 24
NeuroOne® Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
4:10pm
8-K
4pzf4m67o
26 Mar 24
NeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation System
9:20am
8-K
kdjr 5f30sqsgb
15 Mar 24
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
rgehbvtps zw2
13 Feb 24
NeuroOne® Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
4:15pm
8-K
pbyao
14 Dec 23
NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2023 Financial Results and Provides Corporate Update
4:30pm
8-K
k63antdgw
11 Dec 23
NeuroOne® Receives FDA 510(k) Clearance to Market its OneRF™ Ablation System
8:15am
8-K
bl3lmgwasfsl6gh
16 Nov 23
NeuroOne® Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural Probe
8:00am
8-K
t5ziozwwr p2vxiff
14 Nov 23
Volker strengthens existing management team in areas of commercialization, business development, and reimbursement
5:28pm
8-K
sgiumyjsh3snno0 62sv
7 Nov 23
NeuroOne® Provides Progress Update on FDA 510(k) Submission for OneRF™ Ablation System
8:15am
8-K
g4mz1fwerjhlg5ogar
14 Aug 23
NeuroOne® Reports Third Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update
4:15pm
8-K
vhs5butp9h
27 Jul 23
NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock
4:02pm
8-K
pz41yl0rnwjt2
11 May 23
NeuroOne® Reports Second Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update
4:16pm
8-K
3c19ysdydlhr8z
17 Mar 23
Submission of Matters to a Vote of Security Holders
4:34pm
8-K
w6zq79zh7z5wkviw
10 Mar 23
Regulation FD Disclosure
5:00pm
8-K
0liusxua3zx1
14 Feb 23
NeuroOne® Reports First Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update
12:00am